The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Summit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploraroty Phase 2 Clinical Trial at ID Week 2017
Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces its launch as a new company at the World Vaccine Congress
Novel materials enablecontrolled and sustained release of chlorhexidine across a multitude of applications
Leading Contract Development and Manufacturing Organization (CDMO), announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
Evotec has made a € 15 M investment to take a minority stake in Exscientia.
Global pharmaceutical and healthcare company, has exercised its license option to Arecor’s proprietary formulation technology, to develop differentiated biosimilar products.
LiDia™ Bloodstream Infection (BSI) Test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit, London
AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards.
This is the Company’s second orally-active small molecule cancer therapeutic agent to enter clinical trials during the past 12 months.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.